β-catenin downregulation and degradation are observed in non-stem ovarian cancer cells and are positively correlated with TWIST1, which promotes the upregulation of AXIN2, one of the components of the β-catenin destruction complex. The gene discussed is AXIN2; the disease is ovarian cancer.